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Characterizing the Metabolic Fingerprint and
Anti-inflammatory Activity of
Hypericum gentianoides
MATTHEW L. HILLWIG,*,†,‡ KIMBERLY D. P. HAMMER,†,§ DIANE F. BIRT,†,§ AND
EVE SYRKIN WURTELE*,†,‡
Center for Research on Botanical Dietary Supplements, Department of Genetics, Development, and
Cell Biology, and Department of Food Science and Human Nutrition, Iowa State University,
Ames, Iowa 50011
In this paper we characterize the metabolic fingerprint and first reported anti-inflammatory activity of
Hypericum gentianoides. H. gentianoides has a history of medical use by Native Americans, but it
has been studied very little for biological activity. High-performance liquid chromatography (HPLC)
and liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) analyses of a
methanol extract show that H. gentianoides contains a family of over nine related compounds that
have retention times, mass spectra, and a distinctive UV absorption spectra characteristic of certain
acyl-phloroglucinols. These metabolites are abundant relative to other secondary products present
in H. gentianoides, accounting for approximately 0.2 g per gram of dry plant tissue. H. gentianoides
methanol extracts and a specific semipreparative HPLC fraction from these extracts containing the
putative acyl-phloroglucinols reduce prostaglandin E2 synthesis in mammalian macrophages.
KEYWORDS: Hypericum gentianoides; Hypericum perforatum; St. John’s Wort; hyperforin; acyl-phloro-
glucinols; anti-inflammatory; cytotoxicity; PGE2; RAW264.7
INTRODUCTION
The Hypericum genus contains over 450 species; the 75 to
80 species that have been surveyed for phytochemicals to date
are rich in secondary metabolites such as type III polyketides
including flavonoids, xanthones, anthrones, dianthrones, and/
or acyl-phloroglucinols (1). Type III polyketides result from
the condensation of three malonyl-CoA molecules and various
precursor substrates including or derived from branch chain
amino acids, shikimate-derived phenylpropanoids, benzoic acid,
and acetyl-CoA (2) (Figure 1). Divergent type III polyketide
synthases (PKS) have evolved to create this wide variety of
clade-specific polyketides. Chalcone synthase was the first type
III PKS to be characterized, and is the best known (3). The
flavonoids observed in Hypericum species, such as hyperoside,
rutin, isoquercitrin, quercitrin, and quercetin, are derived from
this enzyme’s product, naringenin chalcone. The type III PKS
responsible for emodinanthrone biosynthesis is unknown;
however, biosynthesis of the dianthrone hypericin from emo-
dinanthrone (Figure 1) has been characterized (4). In light of
this diversity, the Hypericum genus represents a great reserve
for the discovery of new bioactive compounds and advancing
our understanding of the underlying mechanisms that cause the
reported bioactivities in humans.
Several Hypericum species, in particular H. perforatum, are
used as herbal treatments for anti-inflammatory, antibacterial,
antiviral, and antidepressive applications (5–7). The numerous
classes of compounds found in this single species may explain
these multiple medicinal uses. For example, acyl-phloroglucinols
have multiple bioactivities, including antibacterial activity in
TLC bioautographic assays (6) and antidepressive properties
in humans (5). Hypericum species are particularly rich in acyl-
phloroglucinols (8). Acyl-phloroglucinols are derived from the
condensation of multiple malonyl-CoA molecules and branch
chain amino acid derivatives (9). These acyl-phloroglucinols
are also often prenylated, as is the case with hyperforin (10).
Acyl-phloroglucinols already identified from Hypericum species
include hyperforin and adhyperforin, perforatumone, uliginosin
A and B, bromouliginosin B, drummondins A-F, saroaspidins
A-C, hyperbrasilols A-C, and numerous sarothralens and
japonicines, paglucinol, annulatophenone, hypericophenonoside,
hyperjovinol A, otogirin, italidipyrone, chinesins I and II, and
sampsonines (6, 8).
Anti-inflammatory activity in mammals and mammalian cells
has been reported for more than one species from the Hypericum
genus (7, 11–13); however, it is unknown whether this is caused
by the same compound(s) in each of these species. This anti-
inflammatory activity has been confirmed by both in vivo studies
treating mice with Hypericum extracts and measuring pain
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reduction using the formalin test (11) and in vitro molecular
studies on H. patulum showing the down-regulation of NF-κB
and the effect of this on PGE2 reduction in LPS-induced C6 rat
glioma cells (14). Extracts or compounds from H. reflexum
reduce inflammatory responses (11), H. laricifolium moderately
reduce cyclooxygenase 1 and 2 activity (12), and H. perforatum
reduce inducible nitrous oxide synthase activity in two human
epithelial cell lines (13), indicating a direct effect of certain
Hypericum metabolite extracts on reducing inflammation.
A few North American species of Hypericum have been used
historically for their medical properties. One such species, H.
gentianoides (orangegrass), is a small perennial that is native
to much of the eastern United States. The Cherokee Native
Americans used this plant for the treatment of fever, gastrointes-
tinal disorders, nosebleeds, sores, and venereal disease (15).
Despite its use by Native Americans, there has been very little
biochemical research on this species. A survey study looking
for the presence of several known compounds in 74 Hypericum
species found that H. gentianoides did not contain hypericin or
hyperforin (16), the two metabolites thought to be the major
bioactive constituents of H. perforatum (17, 18). Because our
initial survey of multiple Hypericum species indicated unusual
metabolites are present in H. gentianoides, and because of the
use of this species by Native Americans, we focus on the
potential bioactivity of this species.
Here, we describe an efficient, nondestructive extraction
method for Hypericum metabolites and a semipreparative
separation method for fractionation of the H. gentianoides
extracts. Using these protocols, we describe the unique me-
tabolite profile of H. gentianoides and demonstrate the anti-
inflammatory activity of this species.
MATERIALS AND METHODS
Extracts. Plant material was collected in October 2004 and
September 2005 from two populations of H. gentianoides growing in
their native habitats in South Carolina by Dr. Joe-Ann McCoy of the
USDA-ARS North Central Regional Plant Introduction Station in Ames,
IA. These populations were accessioned in the US National Plant
Germplasm System as Ames 27657 and Ames 28015. Descriptive
information about these accessions is posted in the Germplasm
Resources Information Network (GRIN) database at http://www.
ars-grin.gov/npgs/. Voucher specimens of these accessions have been
deposited at the Iowa State University Ada Hayden Herbarium. The
aboveground portion of mature flowering plants was harvested and
allowed to dry naturally in a herbarium press before use.
To maximize the discovery of potentially bioactive metabolites, we
developed extraction methods for Hypericum to optimize both the
preservation of unstable compounds and the extraction efficiency of a
broad range of compounds. Methods such as Soxhlet extraction are
efficient; however, such methods can destroy thermally unstable
compounds (19). We ground plant material in liquid nitrogen and used
Figure 1. Hypericum species have evolved a wide array of specialized type III polyketide synthases (PKS) that produce polyketides that may
interact with various receptors/mechanisms/components of potential pathogens, symbionts, predators, and pollinators. Type III polyketides result
from the condensation of three malonyl-CoA molecules and various precursor substrates including branch chain amino acids, shikimate-derived
phenylpropanoids, benzoic acid, and acetyl-CoA (20). Sometimes these polyketides are modified by other enzymes, for example, by prenylation,
as with γ-mangostin (a xanthone) and hyperforin (an acyl-phloroglucinol). The boxes represent type III PKS’s responsible for specific reactions
that form the precursors for secondary metabolites in Hypericum: chalcone synthase (CHS), benzophenone synthase (BPS), and isobutyrophenone
synthase (BUS); and the type III PKS responsible for emodinanthrone biosynthesis (not isolated). The biosynthesis of the dianthrone hypericin
from emodinanthrone has been characterized (21).
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sonication to avoid altering the compounds during extraction to
minimize the degradation of easily oxidized compounds potentially in
H. gentianoides, such as prenylated acyl-phloroglucinols.
Dry plants were ground in liquid nitrogen and 30 g of ground tissue
immersed in 100 mL of methanol. The methanol/tissue was sonicated,
with the tube in ice, using a Cole-Parmer (Chicago, Ill. 60648) 4710
Series Ultrasonic Homogenizer for 30 s three times. Samples were then
centrifuged at 15,000 rcf and the supernatant decanted and filtered
through 0.45 µm nylon syringe filters. Solvent was evaporated under
nitrogen gas at 40 °C to prevent oxidation. Four grams of dry plant
material yielded approximately one gram of extracted methanol-soluble
metabolites. The dried extract was dissolved in cell culture grade
dimethyl sulfoxide (DMSO) (Sigma, St. Louis, MO).
Extraction with an ethanol-water mixture was avoided, despite
efficient extraction, because high temperatures and/or long periods of
time in a lyophilizer or evaporator are required to remove the water
when the sample is concentrated. Methanol was a more logical choice
since that solvent could be evaporated easily and quickly. Furthermore,
it effectively extracted a broad range of compounds similar to those
extracted with 70% ethanol as the solvent (Supporting Information).
High-Performance Liquid Chromatography (HPLC). A Beckman
Coulter HPLC with a Detector 160 photo diode array (PDA) detector
was used for initial chemical profiling. A Synergi Max-RP 4 µm 150
× 4.6 mm column (Phenomenex, Torrance, CA) was used for analytical
separation. For the mobile phase, an acetonitrile/methanol 9:1 v/v
(solvent B) and 10 mM ammonium acetate (solvent A) gradient was
used. The gradient consisted of 87% A/13% B in 10 min to 83% A/17%
B, then to 100% B in 25 min and held for 5 min, at 40 °C. The flow
rate was 1.0 mL/min (20). All solvents were HPLC grade (Sigma, St.
Louis, MO). All standards mentioned where purchased from Chroma-
dex, Irvine, CA.
Liquid Chromatography-Electrospray Ionization-Mass Spec-
trometry (LC-ESI-MS). The extracts were also analyzed with an
Agilent Technologies Ion Trap 1100 LC-ESI-MS. A Synergi Max-RP
4 µm 150 × 4.6 mm column (Phenomenex, Torrance, CA) was used
Figure 2. H. gentianoides contain a distinct set of metabolites not found in H. perforatum. (A) HPLC chromatography of methanol extracts from H.
gentianoides and H. perforatum. Metabolites detected in H. gentianoides and not in H. perforatum are indicated with numbers. Also, many of the
abundant secondary metabolites in H. gentianoides are not found in H. perforatum. LC-MS analysis (mass spectra not shown) indicates hypericin and
hyperforin, ubiquitous in H. perforatum, are not detected in H. gentianoides. (B) The UV absorption fingerprints of the unknown numbered lipophilic
compounds in H. gentianoides are similar, indicating the associated compounds may be related biosynthetically. The mass-to-charge ratio of the molecular
ions from complementary LC-MS data are listed next to their associated UV absorption fingerprint as well. See the Supporting Information for the mass
spectra of peaks 1-9.
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for analytical separation. For the mobile phase an acetonitrile/methanol
9:1 v/v (solvent B) and 10 mM ammonium acetate (solvent A) gradient
was used. The gradient was increased from 85%A/15%B over a 10
min time period to 80% A/20% B, then to 100% B over a 25 min time
period, and held at 100% B for 5 min, at 40 °C. The flow rate was
0.75 mL/min (20). This method and the HPLC method where chosen
for their good separation and short run-time compared to other current
methods used for the analysis of Hypericum extracts. All solvents were
HPLC grade (Sigma, St. Louis, MO).
Semipreparative HPLC. Semipreparative scale HPLC was used
for bioactivity-guided fractionation since it is very reproducible and
requires only gram quantities of starting material. A Synergi Max-RP
4 µm 250 × 10 mm column (Phenomenex Torrance, CA) was chosen,
because its stationary phase matches that of the analytical method. For
the mobile phase, an acetonitrile/methanol 9:1 v/v (solvent B) and 10
mM ammonium acetate (solvent A) gradient elution was used: 13-15%
B in 10 min, 15-100% B in 30 min, 100% B for 5 min, at 40 °C. The
slow rise from 13% to 15% over 10 min optimized the separation of
more polar phenylpropanoids from later eluting flavonoids. While a
range of flow rates from 3-5 mL/min were tested, a flow rate of 4.6
mL/min was selected because it optimized separation of compounds
while matching retention times with the analytical method within 3
min or less. All solvents were HPLC grade (Sigma, St. Louis, MO).
Cell Cultures and Treatments. RAW264.7 macrophages were
cultured as described in Hammer et al. (18). For details see the
Supporting Information. Cells were incubated in media containing 0.1%
DMSO (Sigma, St. Louis, MO), or media with the inclusion of a H.
gentianoides extract or fraction dissolved in DMSO for a final DMSO
concentration of 0.1% of the media to match the controls, with or
without 1 µg/mL LPS (E. coli 02B:B6) (Sigma, St. Louis, MO). Cell
supernatants were collected on ice, and stored in a -70 °C freezer
until used in the PGE2 assay (Supporting Information). Four controls
were included for each experiment: media alone, media and DMSO,
media and LPS, and media and LPS and DMSO. For the PGE2 assays,
treatment of cells with 10 µM quercetin was used as a positive control.
The H. gentianoides methanol extract, and fractions 1 and 2, were dried
under nitrogen gas, weighed, and dissolved in DMSO. The concentration
(tested in µg/mL (dry weight)) represents the final concentration of
the extract, or fraction, in the media. For cytotoxicity studies (Supporting
Information), treatment of cells with 20 µM hypericin was used as a
positive control (17).
Statistical Analysis of Bioactivity and Cytotoxicity Data. Anti-
inflammatory activity was calculated as the mean percent of control in
LPS-induced PGE2 levels ((standard error) as compared to the media
+ LPS + DMSO control. Statistical significance was determined by
an F-protected two-way ANOVA followed by a Tukey-Kramer test
for multiple comparisons (21). For cytotoxicity, data were calculated
as the mean percent cell viability ((standard error) as compared to
the media + DMSO control. Statistical significance was determined
by an F-protected two-way ANOVA followed by a Dunnett-Hsu test
for multiple comparisons (22). P-values less than 0.05 were considered
statistically significant.
RESULTS
Metabolic Profile of H. gentianoides. HPLC-PDA analysis
of H. gentianoides extracts, using the methanol-low temper-
ature extraction method, revealed a complex chromatographic
Figure 3. Semipreparative HPLC separation of H. gentianoides methanol extract. A methanol extract was subjected to semipreparative HPLC and two
fractions collected, dividing the more lipophilic constituents (fraction 2) from the more polar constituents, rich in flavonoids such as quercetin (fraction 1),
as shown in this analytical LC-UV-MS data. The total ion chromatograph (TIC) from the liquid chromatography-electrospray ionization-mass spectrum
analysis shows that the unknown lipophilic compounds (highlighted in the box) based on TIC peak area, comprise approximately 79% of the methanol
extract’s mass, accounting for 2% of the plant fresh weight. This high abundance will facilitate purification of enough material for bioactivity-guided
fractionation starting with only tens of grams of dry plant material.
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profile (Figure 2A). A wavelength of 270 nm is used for
detection in Hypericum extracts surveyed because a wide range
of polyphenolic compounds absorb well at that wavelength.
Chlorogenic acid (A), hyperoside (B), isoquercitrin (C), quer-
citrin (D), and quercetin (E) are present in H. gentianoides as
determined by HPLC-PDA with standards (Figure 2A). The
presence of A, B, and C are in accordance with ref 16, which
used a different H. gentianoides accession.
Other than the presence of chlorogenic acid and the four
flavonoids listed, H. gentianoides has a very distinct chemical
profile compared to that of H. perforatum. Unlike many of the
bioactive species in the Hypericum genus (16), neither hypericin
(a dianthrone) nor hyperforin (an acyl-phloroglucinol), the two
most heavily studied bioactive compounds from St. John’s
Wort (17, 18), are present in H. gentianoides. In addition, the
ultraviolet (UV) radiation absorption spectra of the HPLC UV-
absorbing metabolites reveal a class of related compounds with
a retention time from 30 to 45 min; there are at least nine
metabolites (Figure 2B) with distinctive UV absorption maxima
at 220, 300, and 350 nm or at 226, 287, and 357 nm; the
corresponding LC-ESI-MS data are given in the Supporting
Information.
Also, LC-ESI-MS was used to provide additional physical
information about compounds in the methanol extract used for
fractionation and the anti-inflammatory assays. The total ion
chromatograph (TIC) shows that about 79% of the mass in the
methanol extract consists of compounds with a retention time
between 30 and 35 min, and these compounds comprise 2% of
the fresh weight of the plant (Figure 3). This value was
calculated by using the combined peak area from 30 to 35 min
on the total ion chromatogram (TIC) compared to the total
combined peak area from 0 to 45 min, and the extract yield
from the original extraction. These nine TIC peaks correlate
with the nine UV-absorbing metabolites, as shown with the
corresponding mass-to-charge ratios and retention times shown
in Figure 2B.
Anti-inflammatory Activity of H. gentianoides. To evaluate
the biological activity of H. gentianoides extracts in mammals,
we used a RAW264.7 mouse macrophage model system, in
which LPS is used to induce an inflammatory response (18).
The ability of H. gentianoides extracts to reduce the inflam-
matory response was evaluated by quantifying PGE2 production
in LPS-induced macrophages and comparing to the solvent
control (18). Bioassays using extracts prepared from accessions
Ames 28015 and Ames 27767 of H. gentianoides both produced
a significant reduction of PGE2, compared to the controls. To
establish the concentration of extract needed to demonstrate anti-
inflammatory activity, macrophages were treated with various
concentrations of plant extract from 10 to 50 µg/mL. This
revealed a dose response, with decreasing PGE2 accumulation
the higher the concentrations of the extract applied (Figure 4).
Since H. perforatum contains light-activated compounds, the
H. gentianoides extract was tested in dark conditions and after
light treatment (17) to determine whether the reduction in PGE2
was dependent on light activation. There was no significant
difference in inhibition of PGE2 between the light-activated and
dark treatment conditions (data not shown). Therefore, subse-
quent experiments were performed in light-activated conditions
alone. This confirms results shown in Hammer et al. (18) in
which H. perforatum extracts also had light-independent anti-
inflammatory activity. Also, cytotoxicity was not dependent on
light-activation because there was no significant difference
between light-activated and dark treatment conditions (Sup-
porting Information). The data validate our hypothesis that H.
gentianoides extract, unlike extracts of H. perforatum (23, 24),
does not contain any compounds such as hypericin that would
cause an increased cytotoxicity following light-activation.
Semipreparative HPLC. To determine which classes of
compound(s) are responsible for the bioactivity, and specif-
ically to evaluate the bioactivity of the unidentified metabo-
lites with the distinct UV absorption spectra, a semiprepar-
ative HPLC method was developed to fractionate the H.
gentianoides extract. This optimized protocol achieves good
separation, has a high loading capacity, has the same
compound elution order as the analytical separation data, and
allows for the isolation of enough fraction material for
biological testing in a reasonable amount of time. As an initial
test to determine whether the bioactivity in the H. gen-
Figure 4. H. gentianoides methanol extract significantly reduces PGE2 concentrations in LPS-induced RAW 264.7 macrophages. Cells were treated with
1 µg/mL of LPS and the H. gentianoides extract simultaneously for 8 h. Decreased PGE2 indicates increased anti-inflammatory activity. Anti-inflammatory
activity is given as the mean percent of control (culture media + DMSO + LPS PGE2 level ( standard error) and cytotoxicity is given as the mean
percent of cell viability of control (culture media + DMSO ( standard error) compared to that of H. gentianoides extracts (n ) 6 for each). The
concentration of the extract tested, in µg/mL dry weight, represents the final concentration of the extract in the media. Addition of LPS to the culture
media + DMSO control increased the level of PGE2 11-fold over culture media + DMSO control alone (0.12 ( 0.02 ng/mL for media + DMSO, 1.4
( 0.1 ng/mL for media + DMSO + LPS). Extracts in the culture media without LPS did not affect the concentration of PGE2 as compared to the media
+ DMSO control. (*) p-value less than 0.05 as compared to the control.
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tianoides extract might be associated with the less polar
metabolites with the unique UV spectra, we collected a
fraction from 0 to 30 min (fraction 1) and a fraction from 30
to 45 min (fraction 2). Analytical HPLC separation compares
the composition of the extract to that of the more polar
fraction containing numerous phenylpropanoids and fla-
vonoids (fraction 1) and the less polar fraction (fraction 2)
(Figure 3). This effectively separated the compounds with
the distinct 230/300/350 UV absorption maxima fingerprint
(fraction 2) from the flavonoids and phenylpropanoids to
access if they are responsible for the observed anti-inflam-
matory activity. The UV data for Figure 3 are shown at 350
nm because of the distinct absorption maxima at 350 nm for
the compounds of interest in fraction 2.
Anti-inflammatory Activity of H. gentianoides Fractions.
LPS-induced RAW 264.7 macrophages were treated with one
of the two HPLC fractions or with the original extract. Fraction
2 significantly reduced the PGE2 concentration in the LPS-
induced cells at doses of 30 and 10 µg/mL, while fraction 1
did not reduce the PGE2 concentration at the same doses. This
indicates that the active constituents are in fraction 2 (Figure
5). However, fraction 2 has a small amount of significant
reduction in cell viability at these concentrations. Further testing
revealed that fraction 2 significantly reduces PGE2 concentra-
tions at doses even as low as 1 µg/mL (Figure 5). At 5 and 1
µg/mL, there was no significant reduction in cell viability,
suggesting that these compounds have anti-inflammatory
activity even at these lower doses in which cytotoxicity is
not a concern.
DISCUSSION
In recent years metabolomics has accelerated as a field of
study (25–27). Not only can we use such tools to understand
the biochemistry of an organism and its evolutionary relationship
to its environment, but we can also use them to identify the
compounds responsible for interorganism biological activities.
Recent research on the effect of botanicals on epigenetic events
(28) and cell signaling in mammals (29) implicates that
numerous small molecules most likely play a large part in the
health and life cycle of cells. These findings suggest there are
many more unique small molecules that have yet to be
discovered, which may play crucial roles in cell signaling.
Developing better extraction, separation, and detection methods
is crucial for the identification of bioactive constituents not yet
discovered.
We developed an extraction method for H. gentianoides
designed to minimize degradation of unstable compounds, and
a fractionation method for bioactivity-guided separation of the
extract. Using these procedures, we determined that extracts
from H. gentianoides reduce concentrations of the pro-inflam-
matory compound PGE2 in LPS-induced RAW 264.7 macroph-
ages, and demonstrated that fraction 2 significantly reduces
PGE2 at doses as low as tested, 1 µg/mL, with no significant
reduction in cell viability at this dose. This bioactivity is present
in extracts from both accessions of H. gentianoides sampled,
indicating that the bioactivity is characteristic of at least two
populations of this species.
The reduction in PGE2 concentration by the H. gentianoides
extract may reflect reduced cyclo-oxygenase activity, since
prostaglandin H is the product of this class of enzyme, and is
believed to be the substrate for the biosynthesis of PGE2 by
prostaglandin E synthase. The mechanism by which this PGE2
reduction is modulated is under investigation.
The characteristic UV absorption fingerprints, retention
times, and molecular ions of at least nine HPLC peaks from
the bioactive fraction 2, which are described in Figure 2
Figure 5. H. gentianoides fraction 2 significantly reduces PGE2 concentrations in LPS-induced RAW 264.7 macrophages. Decreased PGE2 indicates
increased anti-inflammatory activity. Anti-inflammatory activity is given as the mean percent of (media + DMSO + LPS PGE2 level ( standard error)
and cytotoxicity is given as the mean percent of (media + DMSO cell viability ( standard error), for fractions 1 and 2, and for extracts of H. gentianoides
(n ) 4 for each). The concentration of the extract tested, in µg/mL dry weight, represents the final concentration of the extract in the media. Fraction
2 significantly reduced PGE2 concentrations at all doses tested and shows no cytotoxicity at doses of 5 µg/mL or less. (*) p-value less than 0.05 as
compared to the control. (**) p-value less than 0.0001 as compared to the control.
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and in the Supporting Information, indicate that its most
abundant constituents may be structurally and/or biosyn-
thetically related, and are consistent with those of certain
types of acyl-phloroglucinols (6). Our working hypothesis
is thus that the anti-inflammatory compounds of H. gen-
tianoides are acyl-phloroglucinols. These compounds may
not have been tested previously for anti-inflammatory proper-
ties considering how few molecular cell biology and bio-
chemical studies on North American Hypericum species have
been published. This complicates the identification of bio-
active constituents given that they must be identified with
NMR since there are no standards available. Fraction 2
contains many compounds besides the nine aforementioned
peaks of interest, and identification of the bioactive metabo-
lites is in progress, using iterative subfractionation, bioactivity
assays, ion trap and quadrapole-time-of-flight (QTOF) LC-
MS, and 2D-NMR spectroscopy.
Furthermore, the distinct morphology as well as the potent
anti-inflammatory bioactivity and unusual chemical profile
of H. gentianoides, relative to other Hypericum species from
Eurasia and North America, justifies further investigation.
A study comparing the chemical profiles of species in the
Section Brathys, to which H. gentianoides belongs, and
species in Section Trigynobrathys, since these sections have
a similar unusual morphology, would enrich the understand-
ing of evolutionary cohorts of H. gentianoides.
SAFETY
Acetonitrile, methanol, ammonium acetate, and dimethyl
sulfoxide are toxic chemicals that should be used in a fume
hood.
ABBREVIATIONS USED
HPLC, high performance liquid chromatography; PDA,
photo diode array; LC-ESI-MS, liquid chromatography-
electrospray ionization-mass spectrometry; PGE2, prostag-
landin E2; LPS, lipopolysaccharide.
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